Same question across reviews · CL0123

intervention :: Exposure/condition: systemic-oral -> Other outcome

ProposalThis cluster groups questions by review type, intervention category and outcome domain. It is a proposal pending human validation, so questions in it may differ in population, comparator or timing.
Reviews
1
Questions
24
current versions
GRADE rated
20
Review overlap (CCA)
NR
over all included studies of these reviews, not this question only
QuestionEffectEvidenceStatus / GRADE
Combined antiretroviral therapy (post-cART) vs Pre-cART (same children, before therapy)
Oral candidiasis prevalence · Children and adolescents (<18 years) living with HIV (CLWH) · After vs before cART (within-person), post-cART vs pre-cART
Impact of Antiretroviral Therapy on Oral Health among Children Living with HIV: A Systematic Review and… (2022)
OR 0.19 [0.15, 0.25]NRVery low
Antiretroviral therapy (any, including cART) vs No antiretroviral medication (treatment-naive)
Parotid hypertrophy prevalence · Children and adolescents (<18 years) living with HIV (CLWH)
Impact of Antiretroviral Therapy on Oral Health among Children Living with HIV: A Systematic Review and… (2022)
OR 0.01 [0.00, 0.05]NRVery low
Antiretroviral therapy (any, including cART) vs No antiretroviral medication (treatment-naive)
Dental development and maturation · Children and adolescents (<18 years) living with HIV (CLWH)
Impact of Antiretroviral Therapy on Oral Health among Children Living with HIV: A Systematic Review and… (2022)
One study (Trigueiro 2010) reported that dental age exceeded chronological age by 5.35 to 14.36 months (SE 3.03 to 15.86) in children on NRTI/PI/NNRTI regimens versus -0.67 months in those without medication; the…1 studyVery low
Antiretroviral therapy (any, including cART) vs No antiretroviral medication (treatment-naive)
Oral hygiene status · Children and adolescents (<18 years) living with HIV (CLWH)
Impact of Antiretroviral Therapy on Oral Health among Children Living with HIV: A Systematic Review and… (2022)
OR 0.73 [0.13, 4.26]0 studiesUngraded
Combined antiretroviral therapy (cART) vs Monotherapy or dual antiretroviral therapy
Angular cheilitis prevalence · Children and adolescents (<18 years) living with HIV (CLWH)
Impact of Antiretroviral Therapy on Oral Health among Children Living with HIV: A Systematic Review and… (2022)
No eligible studies compared angular cheilitis between CLWH on different ART medications.0 studiesNo studies
Combined antiretroviral therapy (cART) vs Monotherapy or dual antiretroviral therapy
Recurrent oral ulceration prevalence · Children and adolescents (<18 years) living with HIV (CLWH)
Impact of Antiretroviral Therapy on Oral Health among Children Living with HIV: A Systematic Review and… (2022)
No significant difference in recurrent oral ulceration between CLWH on cART and those on monotherapy or dual therapy (no numeric estimate reported in the text); 1 study(ies).1 studyVery low
Antiretroviral therapy (any, including cART) vs No antiretroviral medication (treatment-naive)
Mucocele prevalence · Children and adolescents (<18 years) living with HIV (CLWH)
Impact of Antiretroviral Therapy on Oral Health among Children Living with HIV: A Systematic Review and… (2022)
OR 0.02 [0.00, 1.09]NRVery low
Combined antiretroviral therapy (cART) vs No antiretroviral medication (treatment-naive)
Oral candidiasis prevalence · Children and adolescents (<18 years) living with HIV (CLWH) · cART
Impact of Antiretroviral Therapy on Oral Health among Children Living with HIV: A Systematic Review and… (2022)
OR 0.35 [0.24, 0.51]NRVery low
Monotherapy or dual antiretroviral therapy vs No antiretroviral medication (treatment-naive)
Oral candidiasis prevalence · Children and adolescents (<18 years) living with HIV (CLWH) · monotherapy or dual therapy
Impact of Antiretroviral Therapy on Oral Health among Children Living with HIV: A Systematic Review and… (2022)
No significant difference in oral candidiasis prevalence was found between treatment-naive CLWH and those under monotherapy or dual therapy (no numeric estimate reported in the text).NRVery low
Combined antiretroviral therapy (cART) vs Monotherapy or dual antiretroviral therapy
Dental development and maturation · Children and adolescents (<18 years) living with HIV (CLWH)
Impact of Antiretroviral Therapy on Oral Health among Children Living with HIV: A Systematic Review and… (2022)
No eligible studies compared dental development and maturation between CLWH on different ART medications.0 studiesNo studies
Antiretroviral therapy (any, including cART) vs No antiretroviral medication (treatment-naive)
Angular cheilitis prevalence · Children and adolescents (<18 years) living with HIV (CLWH)
Impact of Antiretroviral Therapy on Oral Health among Children Living with HIV: A Systematic Review and… (2022)
OR 0.58 [0.17, 1.99]NRVery low
Antiretroviral therapy (any, including cART) vs No antiretroviral medication (treatment-naive)
Ulcerative stomatitis prevalence · Children and adolescents (<18 years) living with HIV (CLWH)
Impact of Antiretroviral Therapy on Oral Health among Children Living with HIV: A Systematic Review and… (2022)
OR 0.03 [0.02, 0.07]NRVery low
Combined antiretroviral therapy (cART) vs Monotherapy or dual antiretroviral therapy
Acute necrotising ulcerative periodontitis prevalence · Children and adolescents (<18 years) living with HIV (CLWH)
Impact of Antiretroviral Therapy on Oral Health among Children Living with HIV: A Systematic Review and… (2022)
No significant difference in acute necrotising ulcerative periodontitis between CLWH on cART and those on monotherapy or dual therapy (no numeric estimate reported in the text); 1 study(ies).1 studyVery low
Antiretroviral therapy (any, including cART) vs No antiretroviral medication (treatment-naive)
Kaposi's sarcoma prevalence · Children and adolescents (<18 years) living with HIV (CLWH)
Impact of Antiretroviral Therapy on Oral Health among Children Living with HIV: A Systematic Review and… (2022)
OR 0.00 [0.00, 0.03]NRVery low
Combined antiretroviral therapy (cART) vs Monotherapy or dual antiretroviral therapy
Kaposi's sarcoma prevalence · Children and adolescents (<18 years) living with HIV (CLWH)
Impact of Antiretroviral Therapy on Oral Health among Children Living with HIV: A Systematic Review and… (2022)
No significant difference in kaposi's sarcoma between CLWH on cART and those on monotherapy or dual therapy (no numeric estimate reported in the text); 1 study(ies).1 studyVery low
Any antiretroviral therapy vs No antiretroviral medication
Oral candidiasis prevalence · Children and adolescents living with HIV
Impact of Antiretroviral Therapy on Oral Health among Children Living with HIV: A Systematic Review and… (2022)
OR 0.35 [0.19, 0.63]7 studiesVery low
Antiretroviral therapy (any, including cART) vs No antiretroviral medication (treatment-naive)
Recurrent oral ulceration prevalence · Children and adolescents (<18 years) living with HIV (CLWH)
Impact of Antiretroviral Therapy on Oral Health among Children Living with HIV: A Systematic Review and… (2022)
OR 1.50 [0.72, 3.13]NRVery low
Antiretroviral therapy (any, including cART) vs No antiretroviral medication (treatment-naive)
Oral hairy leukoplakia prevalence · Children and adolescents (<18 years) living with HIV (CLWH)
Impact of Antiretroviral Therapy on Oral Health among Children Living with HIV: A Systematic Review and… (2022)
OR 2.75 [0.39, 19.43]NRVery low
Combined antiretroviral therapy (cART) vs Monotherapy or dual antiretroviral therapy
Chronic herpes simplex infection prevalence · Children and adolescents (<18 years) living with HIV (CLWH)
Impact of Antiretroviral Therapy on Oral Health among Children Living with HIV: A Systematic Review and… (2022)
No significant difference in chronic herpes simplex infection between CLWH on cART and those on monotherapy or dual therapy (no numeric estimate reported in the text); 1 study(ies).1 studyVery low
Combined antiretroviral therapy (cART) vs Monotherapy or dual antiretroviral therapy
Oral hairy leukoplakia prevalence · Children and adolescents (<18 years) living with HIV (CLWH)
Impact of Antiretroviral Therapy on Oral Health among Children Living with HIV: A Systematic Review and… (2022)
No eligible studies compared oral hairy leukoplakia between CLWH on different ART medications.0 studiesNo studies
Antiretroviral therapy (any, including cART) vs No antiretroviral medication (treatment-naive)
Mucosal hyperpigmentation prevalence · Children and adolescents (<18 years) living with HIV (CLWH)
Impact of Antiretroviral Therapy on Oral Health among Children Living with HIV: A Systematic Review and… (2022)
OR 1.79 [0.89, 3.61]NRVery low
Antiretroviral therapy (any, including cART) vs No antiretroviral medication (treatment-naive)
Chronic herpes simplex infection prevalence · Children and adolescents (<18 years) living with HIV (CLWH)
Impact of Antiretroviral Therapy on Oral Health among Children Living with HIV: A Systematic Review and… (2022)
OR 2.47 [0.88, 6.97]NRVery low
Combined antiretroviral therapy (cART) vs Monotherapy or dual antiretroviral therapy
Oral candidiasis prevalence · Children and adolescents (<18 years) living with HIV (CLWH)
Impact of Antiretroviral Therapy on Oral Health among Children Living with HIV: A Systematic Review and… (2022)
OR 0.22 [0.16, 0.29]4 studiesVery low
Combined antiretroviral therapy (cART) vs Monotherapy or dual antiretroviral therapy
Persistent parotid enlargement prevalence · Children and adolescents (<18 years) living with HIV (CLWH)
Impact of Antiretroviral Therapy on Oral Health among Children Living with HIV: A Systematic Review and… (2022)
No significant difference in persistent parotid enlargement between CLWH on cART and those on monotherapy or dual therapy (no numeric estimate reported in the text); 1 study(ies).1 studyVery low

Filter these questions further